Category Archives:

PARIS, May 21 (Reuters) - Israeli authorities are currently deporting 37 French nationals who were part of the group of activists on board a Gaza-bound aid flotilla to Turkey, France's Foreign ministr...

(Corrects to say the deal is for Circor Aerospace, not the whole firm, in headline, paragraphs 1 and 2) May 21 (Reuters) - U.S. investment firm KKR said on Thursday it would sell aerospace division of...

WASHINGTON, May 21 (Reuters) - U.S. single-family homebuilding dropped sharply in April and permits for future construction fell, suggesting the housing market could remain subdued for a while as the ...

LONDON, May 21 (Reuters) - Bank of England policymaker Alan Taylor said on Thursday he saw less risk of so-called second-round inflation effects from rising energy prices caused by the Iran war than f...

MOSCOW, May 21 (Reuters) - Ukraine has increased attacks on Russian energy facilities in recent months as peace talks have failed to produce any progress. There are no risks to fuel supplies in Russia...

May 21 (Reuters) - Anthropic is in talks to rent servers powered by Microsoft-designed chips to meet rising demand for its AI services, The Information reported on Thursday, in what would be a major b...

May 21 (Reuters) - Critical Metals said on Thursday it has signed a 15-year binding offtake agreement with REalloys for rare earth concentrate from its Tanbreez project in Greenland. Under the agreeme...

By Ludwig Burger FRANKFURT, May 21 (Reuters) - German federal prosecutors said they brought criminal charges against a Danish and an Afghan national suspected of helping to plot the killing of promine...

May 21 (Reuters) - Crypto brokerage Blockchain.com said on Thursday it has confidentially filed for an initial public offering in the United States, as digital assets markets show signs of a rebound a...

By Sriparna Roy May 21 (Reuters) - Hims & Hers Health said on Thursday it is now offering Canadians a generic version of semaglutide, the active ingredient in Novo Nordisk's blockbuster GLP-1 drugs, t...